In situ Protein Detection for Companion Diagnostics

Area of Science:

• Oncology
• Pathology
• Biotechnology

Background:

• Targeted cancer therapies require companion diagnostics to identify suitable patient populations.
• Immunohistochemistry (IHC) is a key technique for protein expression analysis in tissues.

Purpose of the Study:

• To review established immunohistochemistry methods for routine diagnostics.
• To explore IHC's potential in detecting protein mutations alongside DNA tests.
• To discuss novel protein binders and proximity ligation assays for cancer therapy development.

Main Methods:

• Review of established immunohistochemistry (IHC) protocols.
• Exploration of IHC for protein mutation detection.
• Evaluation of alternative protein binders and proximity ligation assays.

Main Results:

• Immunohistochemistry is a validated method for companion diagnostics in clinical trials and routine practice.
• IHC can complement DNA-based tests for mutation detection.
• Alternative methods show promise for future targeted therapy development.

Conclusions:

• Immunohistochemistry plays a vital role in companion diagnostics for targeted cancer therapies.
• Emerging techniques offer new avenues for developing innovative cancer treatments.